Clinical trial

Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis.

NCT05777902

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2023-01-31

PhasePHASE4

Study timeline

Study start (actual)2023-01-31Date precision: day

Registry last updated2025-01-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Ozanimod Oral CapsuleDRUG · verified · RxNorm: ozanimod Oral Capsule

Sponsors & collaborators

I.R.C.C.S. Fondazione Santa Lucialead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05777902 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.